Targeting HDAC6 to treat heart failure with preserved ejection fraction in mice

Targeting HDAC6 to treat heart failure with preserved ejection fraction in mice

Heart failure with preserved ejection fraction (HFpEF) poses therapeutic challenges due to the limited treatment options. Building upon our previous research that demonstrates the efficacy of histone deacetylase 6 (HDAC6) inhibition in a genetic cardiomyopathy model, we investigate HDAC6's role...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sara Ranjbarvaziri, Aliya Zeng, Iris Wu, Amara Greer-Short, Farshad Farshidfar, Ana Budan, Emma Xu, Reva Shenwai, Matthew Kozubov, Cindy Li, Melissa Van Pell, Francis Grafton, Charles Mackay, Xiaomei Song, James R. Priest, Gretchen Argast, Mohammad A. Mandegar, Timothy Hoey, Jin Yang
Format: Artigo
Langue:anglais
Publié: 2024
Accès en ligne:https://doi.org/10.1038/s41467-024-45440-7
https://www.nature.com/articles/s41467-024-45440-7.pdf
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doi.org/10.1038/s41467-024-45440-7
https://www.nature.com/articles/s41467-024-45440-7.pdf

Documents similaires